M, the device discriminates single-base mismatches and reliably distinguishes EV-miRNA expression differences between normal and M1 disease states. This integrated approach enables low-volume EV enrichment and ultrasensitive EV-miRNA detection, offering a promising platform for clinical analysis of rare samples.
Jiang et al. (Thu,) studied this question.